Citazione:Messaggio inserito da Cleopatra
Caro Matthew
ma io non parlavo dello psorinase... era un post di risposta a Basilio relativamente al collirio Xalatan ed al suo possibile impiego nella calvizie![
]
Ho trovato un interessante articolo in merito, datato 2003, dove l'autore - ipotizzando che il minoxidil abbia un effetto positivo sulla crescita dei capelli in forza dell'azione di stimolo sulla prostaglandina PGE2 - congettura un uso diretto della prostaglandina piuttosto che di uno stimolatore.
Comunque sarebbe interessante sperimentare questo xalatan sui capelli, senza bollarlo tout court come inefficace, anche solo in'un'area limitata dello scalpo.
Allego il link allo studio, naturalmente è in inglese. Buona lettura.
http://dermatology.cdlib.org/93/commentary/alopecia/wolf.html
Un altro articolo conferma l'efficacia sulle scimmie affette da aga
Effect of Latanoprost on Hair Growth in the Bald Scalp of the Stump-tailed Macacque: A Pilot Study
Authors: Uno H.; Zimbric M. L.; Albert D. M.; Stjernschantz J.
Citazione:
Source: Acta Dermato-Venereologica, Volume 82, Number 1, 1 January 2002, pp. 7-12(6)
Publisher: Taylor and Francis Ltd
< previous article | next article > View Table of Contents
full text options
Abstract:
Latanoprost, a selective FP prostanoid receptor agonist used in the treatment of glaucoma, has a hypertrichotic side effect. Using the macaque model of androgenetic alopecia, we examined the effect of latanoprost on hair growth. Eight monkeys were divided into 2 groups; one group received a daily topical application of 50 g/ml of latanoprost for 5 months; a control group had a daily application of vehicle. For an additional 3 months, 2 monkeys from each group were given 500 g/ml latanoprost, while the remaining monkeys continued with the previous treatment. Hair growth was evaluated by monthly photographs and phototricho-graphic analysis. Fifty g/ml of latanoprost caused minimal hair growth. Latanoprost at 500 g/ml induced moderate to marked hair regrowth with 5-10% conversion of vellus hairs to intermediary or terminal hairs. The vehicle group showed no effect. Further evaluation of latanoprost as an agent for treatment of human androgenetic alopecia is indicated.